Antibodies to tumor necrosis factor-α in the treatment of Crohn's disease

Keyphrases

• Tumor Necrosis Factor-α 100%
• Crohn's Disease 100%
• Anti-tumor Necrosis Factor Therapy 40%
• Intestine 40%
• Clinical Response 20%
• Immune Response 20%
• Ulcerative Colitis 20%
• Response to Therapy 20%
• C-reactive Protein 20%
• Response Predictors 20%
• Protein Expression 20%
• Gastrointestinal Tract 20%
• Chronic Intestinal Inflammation 20%
• Fc Receptor 20%
• Colon 20%
• Infliximab 20%
• Immunomodulator 20%
• Etanercept 20%
• Th1 Response 20%
• Bacterial Load 20%
• Dysregulated Immune Response 20%
• Model Support 20%
• Terminal Ileum 20%
• Immune Inhibition 20%
• Protein Polymorphism 20%
• Luminal Microbiota 20%

Immunology and Microbiology

• Tumor Necrosis Factor 100%
• Crohn's Disease 100%
• Immune Response 50%
• Intestine 50%
• Enteritis 25%
• Colon 25%
• Fc Receptor 25%
• Protein Expression 25%
• Infliximab 25%
• Immunomodulating Drugs 25%
• C-Reactive Protein 25%
• Gastrointestinal Tract 25%
• Ulcerative Colitis 25%
• Bacterial Load 25%
• Terminal Ileum 25%
• Etanercept 25%
• Protein Polymorphism 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Tumor Necrosis Factor 100%
• Crohn's Disease 100%
• Necrosis 50%
• Diseases 50%
• C Reactive Protein 25%
• Ulcerative Colitis 25%
• Enteritis 25%
• Infliximab 25%
• Immunomodulating Agent 25%
• Etanercept 25%
• Fc Receptor 25%
• Ileum 25%